MEKTOVI ® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Conditions:   Adamantinous Craniopharyngioma;   Recurrent Adamantinomatous Craniopharyngioma Intervention:   Drug: Binimetinib Oral Tablet [Mektovi] Sponsors:   Nationwide Children's Hospital;   Children's Hospital Colorado Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials